South Korea Neuropsychiatric Disorders Treatment Market Size, Share, and COVID-19 Impact Analysis, By Type (Degenerative Diseases, Neurotic Disorders, Psychosis, and Others), By Application (Shock Treatment, Drug Treatment, and Others), and South Korea Neuropsychiatric Disorders Treatment Market Insights, Industry Trend, Forecasts to 2035

South Korea Neuropsychiatric Disorders Treatment Market Insights Forecasts to 2035

• The South Korea Neuropsychiatric Disorders Treatment Market Size was estimated at USD 3.73 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 9.68% from 2025 to 2035
• The South Korea Neuropsychiatric Disorders Treatment Market Size is Expected to Reach USD 10.31 Million by 2035

According to a research report published by Spherical Insights & Consulting, the South Korea Neuropsychiatric Disorders Treatment Market is anticipated to reach USD 10.31million by 2035, growing at a CAGR of 9.68% from 2025 to 2035. driven by government programs, aging populations, and growing mental health awareness. The need for advanced therapies is being driven by an increase in the diagnosis of degenerative diseases like Alzheimer's, anxiety, and depression.

Market Overview

The South Korea neuropsychiatric disorders treatment market refers to the healthcare industry devoted to identifying, treating, and managing mental and neurological disorders like depression, anxiety, schizophrenia, bipolar disorder, and degenerative diseases like Alzheimer's and Parkinson's is known as the South Korean neuropsychiatric disorders treatment market. Additionally, significant trends in the South Korean market for the treatment of neuropsychiatric disorders are being shaped by a number of factors. Market growth is being restrained by a rise in awareness of mental health issues as well as continuous shifts in societal perceptions regarding the behavior of seeking help for neuropsychiatric disorders. With a particular emphasis on early intervention, the South Korean government has been implementing mental health policies. Furthermore, more specialized treatment facilities and telemedicine are now available, which has improved access to therapy. This parallels the rise in digital health, or the use of technology in healthcare, which has become popular in South Korea.

Report Coverage

This research report categorizes the market for the South Korea neuropsychiatric disorders treatment market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea neuropsychiatric disorders treatment market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea neuropsychiatric disorders treatment market.

Driving Factors

In South Korea, attitudes toward mental health have significantly changed, raising awareness and reducing the stigma attached to getting help. Governmental and nonprofit organizations are spearheading initiatives to increase public awareness of mental health issues. Approximately 65% of South Koreans are now more open to talking about mental health issues in public than they were five years ago, according to statistics. More people are seeking treatment as a result of these shifting attitudes, which is driving the growth of the South Korean neuropsychiatric disorders treatment market. In order to create a supportive atmosphere for individuals impacted, community organizations' participation in these awareness campaigns is essential.

Restraining Factors

The market for neuropsychiatric disorders in South Korea is constrained by the high expense of treatment, the lack of insurance coverage, and the scarcity of qualified specialists. Accessibility is also hampered by social stigma, a disjointed healthcare system, and the sluggish uptake of cutting-edge treatments. Even though the demand for mental health solutions is rising, regulatory complexity and low awareness in rural areas make market expansion even more difficult.

Market Segmentation

The South Korea neuropsychiatric disorders treatment market share is classified into type and application.

• The degenerative diseases segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea neuropsychiatric disorders treatment market is segmented by type into degenerative diseases, neurotic disorders, psychosis, and others. Among these, the degenerative diseases segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Degenerative diseases, like Parkinson's and Alzheimer's, are very important because of the aging population and the rise in cognitive disorders. The nation's dedication to enhancing mental health and senior care services demonstrates the increasing recognition of these difficulties.

• The drug treatment segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea neuropsychiatric disorders treatment market is segmented by shock treatment, drug treatment, and others. Among these, the drug treatment segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Contrariwise, drug treatment is still a vital option, with a wide variety of pharmacological solutions that target various disorders and are greatly supported by continuing research and development in the field.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea neuropsychiatric disorders treatment market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Hanmi Pharmaceutical
• LG Chem Life Sciences
• Samsung Biologics
• SK Biopharmaceuticals
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Neuropsychiatric Disorders Treatment Market based on the below-mentioned segments:

South Korea Neuropsychiatric Disorders Treatment Market, By Type

• Degenerative Diseases
• Neurotic Disorders
• Psychosis
• Others

South Korea Neuropsychiatric Disorders Treatment Market, By Application

• Shock Treatment
• Drug Treatment
• Others